TY - JOUR
T1 - The Cervical Dysplasia Worksheet
T2 - A Longitudinal Map of Cervical Dysplasia Cytology and Histology Tests and Procedures
AU - Johnson, Camille A.
AU - Madrigal, Jessica M.
AU - Metoyer, Kelly
AU - Zhukovsky, Sara D.
AU - Patel, Ashlesha
N1 - Funding Information:
1Department of Obstetrics and Gynecology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL; 2Rush Medical College, Rush University Medical Center, Chicago, IL; 3Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL; and 4Department of Obstetrics and Gynecology, Northwestern University, Feinberg School of Medicine, Chicago, IL All analyses, interpretations, or conclusions are those of the authors and not of the funders. A.P. is a Nexplanon trainer for Merck & Co, Inc, part of the Speaker's Bureau for Allergan, and receives grant support from Bayer and CooperSurgical. The remaining authors have declared they have no conflicts of interest. This study was approved by the Cook County Health Institutional Review Board. Correspondence to: Ashlesha Patel, MD, MPH, Department of Obstetrics and Gynecology John H Stroger, Jr. Hospital of Cook County, 1950 W Polk St, 7th Flr, Chicago, IL 60612 Chicago, IL 60612. E-mail: apatel2@cookcountyhhs.org Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jlgtd.com). © 2020, ASCCP DOI: 10.1097/LGT.0000000000000566
Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Objective Our objectives were to describe the Cervical Dysplasia Worksheet (CDW), provide evidence of its feasibility to view patient cervical dysplasia results over time, and evaluate patient attitudes toward the tool in the setting of abnormal result follow-up. Materials and Methods The CDW augments the ASCCP guidelines for managing abnormal cervical cancer screenings by visually depicting cervical cytological and histological history along a color gradient showing severity. We evaluated tool feasibility by graphing a retrospectively reviewed convenience sample of patient data. A cross-sectional evaluation of the tool was then performed to assess patient attitudes in the setting of either dysplasia or colposcopy clinic. Patients had their data graphed on the CDW and explained to them before their clinical encounter. They then gave general comments about the tool and filled out a short evaluation survey. Results The large majority of retrospective patient data (N = 167) fit well within the CDW with roughly 20% requiring space for additional comments. Among the 30 patients who participated in our evaluation, almost all agreed (n = 29, 96.7%) that the tool helped them understand their history and results and that they would use the tool in the future. Conclusions The CDW is a novel tool to display a patient's cervical dysplasia history to visualize treatment and future care while enhancing patient-provider communication. Patient evaluation of the tool was largely positive, and suggestions will be taken into consideration for future modification. Further evaluation of the CDW among healthcare providers is needed to analyze its efficacy in the clinical setting.
AB - Objective Our objectives were to describe the Cervical Dysplasia Worksheet (CDW), provide evidence of its feasibility to view patient cervical dysplasia results over time, and evaluate patient attitudes toward the tool in the setting of abnormal result follow-up. Materials and Methods The CDW augments the ASCCP guidelines for managing abnormal cervical cancer screenings by visually depicting cervical cytological and histological history along a color gradient showing severity. We evaluated tool feasibility by graphing a retrospectively reviewed convenience sample of patient data. A cross-sectional evaluation of the tool was then performed to assess patient attitudes in the setting of either dysplasia or colposcopy clinic. Patients had their data graphed on the CDW and explained to them before their clinical encounter. They then gave general comments about the tool and filled out a short evaluation survey. Results The large majority of retrospective patient data (N = 167) fit well within the CDW with roughly 20% requiring space for additional comments. Among the 30 patients who participated in our evaluation, almost all agreed (n = 29, 96.7%) that the tool helped them understand their history and results and that they would use the tool in the future. Conclusions The CDW is a novel tool to display a patient's cervical dysplasia history to visualize treatment and future care while enhancing patient-provider communication. Patient evaluation of the tool was largely positive, and suggestions will be taken into consideration for future modification. Further evaluation of the CDW among healthcare providers is needed to analyze its efficacy in the clinical setting.
KW - cervical cancer screening
KW - health communication
KW - patient-centered care
KW - uterine cervical cancer
KW - uterine cervical dysplasia
KW - visual aid
UR - http://www.scopus.com/inward/record.url?scp=85091807851&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091807851&partnerID=8YFLogxK
U2 - 10.1097/LGT.0000000000000566
DO - 10.1097/LGT.0000000000000566
M3 - Article
C2 - 32976293
AN - SCOPUS:85091807851
SN - 1089-2591
VL - 24
SP - 343
EP - 348
JO - Journal of Lower Genital Tract Disease
JF - Journal of Lower Genital Tract Disease
IS - 4
ER -